Javier Cortés, MD, PhD, and Julia Rotow, MD, discuss NSCLC in this CME activity titled "Updates on HER3-Targeted Therapies in NSCLC and Breast Cancer." For the full presentation, please visit us at www.peervoice.com/TXH870.
Case Study Challenge: Managing FLT3-ITD–Positive AMLPeerVoice
Michael Heuser, MD, discusses AML in this IME activity titled "Case Study Challenge: Managing FLT3-ITD–Positive AML." For the full presentation, please visit us at www.peervoice.com/APW870.
The Central Role of the Pathologist in Detecting MET Alterations: Enabling Mu...PeerVoice
Jonathan W. Riess, MD, MS, Mary Beth Beasley, MD, and Gerard A. Silvestri, MD, MS, Master FCCP, discuss NSCLC in this CME activity titled "The Central Role of the Pathologist in Detecting MET Alterations: Enabling Multidisciplinary Teams to Do More With Less in NSCLC." For the full presentation, please visit us at www.peervoice.com/QHY870.
Multiple Sclerosis and Bruton’s Tyrosine Kinase Inhibitors: Therapeutic Poten...PeerVoice
Xavier Montalban, MD, PhD, and Jiwon Oh, MD, PhD, FRCPC, discuss multiple sclerosis in this CE activity titled "Multiple Sclerosis and Bruton’s Tyrosine Kinase Inhibitors: Therapeutic Potential Beyond Biologics?" For the full presentation, please visit us at www.peervoice.com/BBT870.
Differentiating Between BTK Inhibitors in CLL: Same Class, Distinctly Dissimi...PeerVoice
Lindsey Roeker, MD discusses chronic lymphocytic leukaemia in this CME activity titled "Differentiating Between BTK Inhibitors in CLL: Same Class, Distinctly Dissimilar Agents." For the full presentation, please visit us at www.peervoice.com/HZH870.
A New Jigsaw Piece for Our Patient’s Puzzle: TROP2-Directed Therapy in HR+ Ad...PeerVoice
Sara Hurvitz, MD, Hope S. Rugo, MD, FASCO, and Paolo Tarantino, MD, discuss breast cancer in this CME activity titled "A New Jigsaw Piece for Our Patient’s Puzzle: TROP2-Directed Therapy in HR+ Advanced Breast Cancer." For the full presentation, please visit us at www.peervoice.com/UGT870.
Practical Considerations for FLT3 Inhibitors in Acute Myeloid Leukaemia: Opti...PeerVoice
Christian Récher, MD, PhD, Pau Montesinos, MD, PhD, and Christian Thiede, MD, discuss acute myeloid leukaemia in this IME activity titled "Practical Considerations for FLT3 Inhibitors in Acute Myeloid Leukaemia: Optimising Our First-Line Approaches With Current and Novel Therapeutics." For the full presentation, please visit us at www.peervoice.com/GYE870.
Treating T2D in People of Younger Age in This Day and Age: How Would You Mana...PeerVoice
Maria Craig, MBBS, PhD, FRACP, MMed(ClinEpid) and Timothy Barrett, MB, BS, PhD discuss type 2 diabetes in children and adolescents in this CE activity titled "Treating T2D in People of Younger Age in This Day and Age: How Would You Manage These Children and Adolescents With T2D?" For the full presentation, please visit us at www.peervoice.com/GBR870.
Optimising Outcomes for Our Patients With Advanced Urothelial Carcinoma: Best...PeerVoice
Thomas Powles, MBBS, MRCP, MD, discusses urothelial carcinoma in this CE activity titled "Optimising Outcomes for Our Patients With Advanced Urothelial Carcinoma: Best Practices and Future Directions in Maintenance Therapy." For the full presentation, please visit us at www.peervoice.com/NYE870.
Case Study Challenge: Managing FLT3-ITD–Positive AMLPeerVoice
Michael Heuser, MD, discusses AML in this IME activity titled "Case Study Challenge: Managing FLT3-ITD–Positive AML." For the full presentation, please visit us at www.peervoice.com/APW870.
The Central Role of the Pathologist in Detecting MET Alterations: Enabling Mu...PeerVoice
Jonathan W. Riess, MD, MS, Mary Beth Beasley, MD, and Gerard A. Silvestri, MD, MS, Master FCCP, discuss NSCLC in this CME activity titled "The Central Role of the Pathologist in Detecting MET Alterations: Enabling Multidisciplinary Teams to Do More With Less in NSCLC." For the full presentation, please visit us at www.peervoice.com/QHY870.
Multiple Sclerosis and Bruton’s Tyrosine Kinase Inhibitors: Therapeutic Poten...PeerVoice
Xavier Montalban, MD, PhD, and Jiwon Oh, MD, PhD, FRCPC, discuss multiple sclerosis in this CE activity titled "Multiple Sclerosis and Bruton’s Tyrosine Kinase Inhibitors: Therapeutic Potential Beyond Biologics?" For the full presentation, please visit us at www.peervoice.com/BBT870.
Differentiating Between BTK Inhibitors in CLL: Same Class, Distinctly Dissimi...PeerVoice
Lindsey Roeker, MD discusses chronic lymphocytic leukaemia in this CME activity titled "Differentiating Between BTK Inhibitors in CLL: Same Class, Distinctly Dissimilar Agents." For the full presentation, please visit us at www.peervoice.com/HZH870.
A New Jigsaw Piece for Our Patient’s Puzzle: TROP2-Directed Therapy in HR+ Ad...PeerVoice
Sara Hurvitz, MD, Hope S. Rugo, MD, FASCO, and Paolo Tarantino, MD, discuss breast cancer in this CME activity titled "A New Jigsaw Piece for Our Patient’s Puzzle: TROP2-Directed Therapy in HR+ Advanced Breast Cancer." For the full presentation, please visit us at www.peervoice.com/UGT870.
Practical Considerations for FLT3 Inhibitors in Acute Myeloid Leukaemia: Opti...PeerVoice
Christian Récher, MD, PhD, Pau Montesinos, MD, PhD, and Christian Thiede, MD, discuss acute myeloid leukaemia in this IME activity titled "Practical Considerations for FLT3 Inhibitors in Acute Myeloid Leukaemia: Optimising Our First-Line Approaches With Current and Novel Therapeutics." For the full presentation, please visit us at www.peervoice.com/GYE870.
Treating T2D in People of Younger Age in This Day and Age: How Would You Mana...PeerVoice
Maria Craig, MBBS, PhD, FRACP, MMed(ClinEpid) and Timothy Barrett, MB, BS, PhD discuss type 2 diabetes in children and adolescents in this CE activity titled "Treating T2D in People of Younger Age in This Day and Age: How Would You Manage These Children and Adolescents With T2D?" For the full presentation, please visit us at www.peervoice.com/GBR870.
Optimising Outcomes for Our Patients With Advanced Urothelial Carcinoma: Best...PeerVoice
Thomas Powles, MBBS, MRCP, MD, discusses urothelial carcinoma in this CE activity titled "Optimising Outcomes for Our Patients With Advanced Urothelial Carcinoma: Best Practices and Future Directions in Maintenance Therapy." For the full presentation, please visit us at www.peervoice.com/NYE870.
The Quest for Optimal Haemolytic Control of Paroxysmal Nocturnal HaemoglobinuriaPeerVoice
Jeffrey Szer, MBBS, FRACP, discusses PNH in this IME activity titled "The Quest for Optimal Haemolytic Control of Paroxysmal Nocturnal Haemoglobinuria." For the full presentation, please visit us at www.peervoice.com/ZHK870.
When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease o...PeerVoice
Asma Khalil, MBBCh, MD(Res), FRCOG, MSc(Epi), and Enrico Lopriore, MD, PhD, discuss haemolytic disease of the fetus and newborn in this CE activity titled "When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease of the Fetus and Newborn." For the full presentation, please visit us at www.peervoice.com/BKD870.
CGA - Identify and Intervene: Optimising Care Pathways for Chronic Kidney Dis...PeerVoice
Fatos Pinar Topsever, MD and Jennifer Green, MD discuss CKD in T2DM in this CME activity titled "CGA - Identify and Intervene: Optimising Care Pathways for Chronic Kidney Disease in Patients With Type 2 Diabetes." For the full presentation, please visit us at www.peervoice.com/QKR870.
Are You Forearmed When Managing Toxicities Associated With Chemoradiotherapy ...PeerVoice
Lisa Licitra, MD, and Barbara Burtness, MD, discuss head and neck cancer in this CE activity titled "Are You Forearmed When Managing Toxicities Associated With Chemoradiotherapy in Patients With SCCHN?" For the full presentation, please visit us at www.peervoice.com/YZV870.
Navigating Decisions With Limited Tools: A Review of Best Practices in Managi...PeerVoice
Dirk Arnold, MD, Chiara Cremolini, MD, PhD, and Nicola Normanno, MD, discuss metastatic colorectal cancer in this CE activity titled "Navigating Decisions With Limited Tools: A Review of Best Practices in Managing Metastatic Colorectal Cancer." For the full presentation, please visit us at www.peervoice.com/RAS870.
Neuroimmunology Matters: A Specific Review of Emerging Targeted Strategies fo...PeerVoice
Ali Aamer Habib, MD, and Martijn Tannemaat, MD, PhD, discuss generalised myasthenia gravis in this CE activity titled "Neuroimmunology Matters: A Specific Review of Emerging Targeted Strategies for Generalised Myasthenia Gravis." For the full presentation, please visit us at www.peervoice.com/JEG870.
Don’t Forget About MET: Keys to Detecting and Targeting MET Alterations as a ...PeerVoice
Jonathan W. Goldman, MD, Xiuning Le, MD, PhD, and Diana N. Ionescu, MD, discuss NSCLC in this IME activity titled "Don’t Forget About MET: Keys to Detecting and Targeting MET Alterations as a Therapeutic Vulnerability in NSCLC." For the full presentation, please visit us at www.peervoice.com/HPP870.
Practical Perspectives and Straightforward Strategies for Optimising GDMT in ...PeerVoice
Javed Butler, MD, MPH, MBA, Michael Böhm, MD, Alexandre Mebazaa, MD, PhD, and Antoni Bayés-Genís, MD, PhD, FESC, FHFA, discuss heart failure in this CE activity titled "Practical Perspectives and Straightforward Strategies for Optimising GDMT in HFrEF: The Role of ARNI as a Fundamental Building Block." For the full presentation, please visit us at www.peervoice.com/QJJ870.
MDT Management of Patients Receiving Radioligand Therapy: Strategies to Optim...PeerVoice
Bertrand Tombal, MD, PhD, Edmund Chiong, MBBS, PhD, FRCS / FAMS, and Louise Emmett, MBChB, MD, discuss prostate cancer in this IME activity titled "MDT Management of Patients Receiving Radioligand Therapy: Strategies to Optimise Outcomes." For the full presentation, please visit us at www.peervoice.com/EUM870.
Taking the Evidence from Paper to Practice: Shared Perspectives on Practical ...PeerVoice
Wisia Wedzicha, MD, FRCP and Alberto Papi, MD discuss chronic obstructive pulmonary disease in this [CME] activity titled "Taking the Evidence from Paper to Practice: Shared Perspectives on Practical Considerations in Comprehensive COPD Care." For the full presentation, please visit us at www.peervoice.com/ZFW870.
Disruption at the Neuromuscular Junction: Relevance of Autoantibodies to Ther...PeerVoice
Nils Erik Gilhus, MD, PhD, and Sarah Hoffmann, MD, PhD, MSc, discuss generalised myasthenia gravis in this CE activity titled "Disruption at the Neuromuscular Junction: Relevance of Autoantibodies to Therapy in Generalised Myasthenia Gravis." For the full presentation, please visit us at www.peervoice.com/PBV870.
The Science and the Art of Sequencing Therapies in Advanced CRC Beyond the Se...PeerVoice
Marwan Fakih, MD, discusses colorectal cancer in this CME activity titled "The Science and the Art of Sequencing Therapies in Advanced CRC Beyond the Second Line." For the full presentation, please visit us at www.peervoice.com/SSC870.
Expert Lines of Thought in Sequencing Later Lines of Therapy in Advanced CRCPeerVoice
Marwan Fakih, MD, Tanios Bekaii-Saab, MD, and Dustin Deming, MD, discuss colorectal cancer in this CME activity titled "Expert Lines of Thought in Sequencing Later Lines of Therapy in Advanced CRC." For the full presentation, please visit us at www.peervoice.com/AQR870.
The Case for Improved Care in COPD: Appreciating COPD as a Leading Cause of D...PeerVoice
David M. G. Halpin, MB BS, DPhil, FERS discusses chronic obstructive pulmonary disease in this CME activity titled "The Case for Improved Care in COPD: Appreciating COPD as a Leading Cause of Disability and Death." For the full presentation, please visit us at www.peervoice.com/UWS870.
TROP2-Directed Antibody-Drug Conjugates for Breast Cancer: The Clinical Signi...PeerVoice
Ana C. Garrido-Castro, MD and Sarah L. Sammons, MD discuss breast cancer in this CME activity titled "TROP2-Directed Antibody-Drug Conjugates for Breast Cancer: The Clinical Significance of the Construct." For the full presentation, please visit us at www.peervoice.com/JJH870.
Building a Better Approach to Obesity Care in Our Clinical PracticesPeerVoice
Carel le Roux, MD, PhD, discusses obesity in this CME activity titled "Building a Better Approach to Obesity Care in Our Clinical Practices." For the full presentation, please visit us at www.peervoice.com/HPE870.
Catch Them Before They Fall: A Call to Action for Comprehensive Testing for H...PeerVoice
Laurent Servais, MD, PhD and Giovanni Baranello, MD, PhD discuss the clinical presentation of hypotonia in this IME activity titled "Catch Them Before They Fall: A Call to Action for Comprehensive Testing for Hypotonia in Paediatric Patients." For the full presentation, please visit us at www.peervoice.com/SNX870.
Radioligand Therapy and Therapeutic Sequencing in mCRPCPeerVoice
Elena Castro, MD, PhD, discusses prostate cancer in this IME activity titled "Radioligand Therapy and Therapeutic Sequencing in mCRPC." For the full presentation, please visit us at www.peervoice.com/AKT870.
Multidisciplinary Perspectives on Advanced Management of CPF in CD: Exploring...PeerVoice
Philip James Tozer, MBBS, MD(Res), FRCS, Krisztina Barbara Gecse, MD, PhD, and Jordi Rimola, MD, PhD, discuss complex perianal fistula in this CME activity titled "Multidisciplinary Perspectives on Advanced Management of CPF in CD: Exploring the Who, When, and How for Stem Cell Therapy." For the full presentation, please visit us at www.peervoice.com/GWC870.
Approaching Airway Inflammation From Another Angle: The Rationale for Targeti...PeerVoice
Claus Vogelmeier, MD, and Nicola Hanania, MD, MS, discuss chronic obstructive pulmonary disease in this CE activity titled "Approaching Airway Inflammation From Another Angle: The Rationale for Targeting Type 2 Pathways in COPD." For the full presentation, please visit us at www.peervoice.com/JHP870.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
The Quest for Optimal Haemolytic Control of Paroxysmal Nocturnal HaemoglobinuriaPeerVoice
Jeffrey Szer, MBBS, FRACP, discusses PNH in this IME activity titled "The Quest for Optimal Haemolytic Control of Paroxysmal Nocturnal Haemoglobinuria." For the full presentation, please visit us at www.peervoice.com/ZHK870.
When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease o...PeerVoice
Asma Khalil, MBBCh, MD(Res), FRCOG, MSc(Epi), and Enrico Lopriore, MD, PhD, discuss haemolytic disease of the fetus and newborn in this CE activity titled "When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease of the Fetus and Newborn." For the full presentation, please visit us at www.peervoice.com/BKD870.
CGA - Identify and Intervene: Optimising Care Pathways for Chronic Kidney Dis...PeerVoice
Fatos Pinar Topsever, MD and Jennifer Green, MD discuss CKD in T2DM in this CME activity titled "CGA - Identify and Intervene: Optimising Care Pathways for Chronic Kidney Disease in Patients With Type 2 Diabetes." For the full presentation, please visit us at www.peervoice.com/QKR870.
Are You Forearmed When Managing Toxicities Associated With Chemoradiotherapy ...PeerVoice
Lisa Licitra, MD, and Barbara Burtness, MD, discuss head and neck cancer in this CE activity titled "Are You Forearmed When Managing Toxicities Associated With Chemoradiotherapy in Patients With SCCHN?" For the full presentation, please visit us at www.peervoice.com/YZV870.
Navigating Decisions With Limited Tools: A Review of Best Practices in Managi...PeerVoice
Dirk Arnold, MD, Chiara Cremolini, MD, PhD, and Nicola Normanno, MD, discuss metastatic colorectal cancer in this CE activity titled "Navigating Decisions With Limited Tools: A Review of Best Practices in Managing Metastatic Colorectal Cancer." For the full presentation, please visit us at www.peervoice.com/RAS870.
Neuroimmunology Matters: A Specific Review of Emerging Targeted Strategies fo...PeerVoice
Ali Aamer Habib, MD, and Martijn Tannemaat, MD, PhD, discuss generalised myasthenia gravis in this CE activity titled "Neuroimmunology Matters: A Specific Review of Emerging Targeted Strategies for Generalised Myasthenia Gravis." For the full presentation, please visit us at www.peervoice.com/JEG870.
Don’t Forget About MET: Keys to Detecting and Targeting MET Alterations as a ...PeerVoice
Jonathan W. Goldman, MD, Xiuning Le, MD, PhD, and Diana N. Ionescu, MD, discuss NSCLC in this IME activity titled "Don’t Forget About MET: Keys to Detecting and Targeting MET Alterations as a Therapeutic Vulnerability in NSCLC." For the full presentation, please visit us at www.peervoice.com/HPP870.
Practical Perspectives and Straightforward Strategies for Optimising GDMT in ...PeerVoice
Javed Butler, MD, MPH, MBA, Michael Böhm, MD, Alexandre Mebazaa, MD, PhD, and Antoni Bayés-Genís, MD, PhD, FESC, FHFA, discuss heart failure in this CE activity titled "Practical Perspectives and Straightforward Strategies for Optimising GDMT in HFrEF: The Role of ARNI as a Fundamental Building Block." For the full presentation, please visit us at www.peervoice.com/QJJ870.
MDT Management of Patients Receiving Radioligand Therapy: Strategies to Optim...PeerVoice
Bertrand Tombal, MD, PhD, Edmund Chiong, MBBS, PhD, FRCS / FAMS, and Louise Emmett, MBChB, MD, discuss prostate cancer in this IME activity titled "MDT Management of Patients Receiving Radioligand Therapy: Strategies to Optimise Outcomes." For the full presentation, please visit us at www.peervoice.com/EUM870.
Taking the Evidence from Paper to Practice: Shared Perspectives on Practical ...PeerVoice
Wisia Wedzicha, MD, FRCP and Alberto Papi, MD discuss chronic obstructive pulmonary disease in this [CME] activity titled "Taking the Evidence from Paper to Practice: Shared Perspectives on Practical Considerations in Comprehensive COPD Care." For the full presentation, please visit us at www.peervoice.com/ZFW870.
Disruption at the Neuromuscular Junction: Relevance of Autoantibodies to Ther...PeerVoice
Nils Erik Gilhus, MD, PhD, and Sarah Hoffmann, MD, PhD, MSc, discuss generalised myasthenia gravis in this CE activity titled "Disruption at the Neuromuscular Junction: Relevance of Autoantibodies to Therapy in Generalised Myasthenia Gravis." For the full presentation, please visit us at www.peervoice.com/PBV870.
The Science and the Art of Sequencing Therapies in Advanced CRC Beyond the Se...PeerVoice
Marwan Fakih, MD, discusses colorectal cancer in this CME activity titled "The Science and the Art of Sequencing Therapies in Advanced CRC Beyond the Second Line." For the full presentation, please visit us at www.peervoice.com/SSC870.
Expert Lines of Thought in Sequencing Later Lines of Therapy in Advanced CRCPeerVoice
Marwan Fakih, MD, Tanios Bekaii-Saab, MD, and Dustin Deming, MD, discuss colorectal cancer in this CME activity titled "Expert Lines of Thought in Sequencing Later Lines of Therapy in Advanced CRC." For the full presentation, please visit us at www.peervoice.com/AQR870.
The Case for Improved Care in COPD: Appreciating COPD as a Leading Cause of D...PeerVoice
David M. G. Halpin, MB BS, DPhil, FERS discusses chronic obstructive pulmonary disease in this CME activity titled "The Case for Improved Care in COPD: Appreciating COPD as a Leading Cause of Disability and Death." For the full presentation, please visit us at www.peervoice.com/UWS870.
TROP2-Directed Antibody-Drug Conjugates for Breast Cancer: The Clinical Signi...PeerVoice
Ana C. Garrido-Castro, MD and Sarah L. Sammons, MD discuss breast cancer in this CME activity titled "TROP2-Directed Antibody-Drug Conjugates for Breast Cancer: The Clinical Significance of the Construct." For the full presentation, please visit us at www.peervoice.com/JJH870.
Building a Better Approach to Obesity Care in Our Clinical PracticesPeerVoice
Carel le Roux, MD, PhD, discusses obesity in this CME activity titled "Building a Better Approach to Obesity Care in Our Clinical Practices." For the full presentation, please visit us at www.peervoice.com/HPE870.
Catch Them Before They Fall: A Call to Action for Comprehensive Testing for H...PeerVoice
Laurent Servais, MD, PhD and Giovanni Baranello, MD, PhD discuss the clinical presentation of hypotonia in this IME activity titled "Catch Them Before They Fall: A Call to Action for Comprehensive Testing for Hypotonia in Paediatric Patients." For the full presentation, please visit us at www.peervoice.com/SNX870.
Radioligand Therapy and Therapeutic Sequencing in mCRPCPeerVoice
Elena Castro, MD, PhD, discusses prostate cancer in this IME activity titled "Radioligand Therapy and Therapeutic Sequencing in mCRPC." For the full presentation, please visit us at www.peervoice.com/AKT870.
Multidisciplinary Perspectives on Advanced Management of CPF in CD: Exploring...PeerVoice
Philip James Tozer, MBBS, MD(Res), FRCS, Krisztina Barbara Gecse, MD, PhD, and Jordi Rimola, MD, PhD, discuss complex perianal fistula in this CME activity titled "Multidisciplinary Perspectives on Advanced Management of CPF in CD: Exploring the Who, When, and How for Stem Cell Therapy." For the full presentation, please visit us at www.peervoice.com/GWC870.
Approaching Airway Inflammation From Another Angle: The Rationale for Targeti...PeerVoice
Claus Vogelmeier, MD, and Nicola Hanania, MD, MS, discuss chronic obstructive pulmonary disease in this CE activity titled "Approaching Airway Inflammation From Another Angle: The Rationale for Targeting Type 2 Pathways in COPD." For the full presentation, please visit us at www.peervoice.com/JHP870.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.